Disclaimer

The materials on this site are provided for informational purposes only, do not constitute legal advice, and are not guaranteed to be correct, complete, or up-to-date.

Attorney-Client Relationship:

This site is not intended to create an attorney-client relationship between you and Verrill, and you should not act or rely on any information in this site without seeking the advice of an attorney. Any communication with us does not create an attorney-client relationship.

We would be pleased to communicate with you by e-mail. However, if you communicate with us--through this site or otherwise--in connection with a matter for which we do not already represent you, your communication may not be treated as privileged or confidential. If you communicate with us by e-mail in connection with a matter for which we do already represent you, please remember that internet e-mail is not secure and you should avoid sending sensitive or confidential messages unless they are adequately encrypted. When communicating with us by e-mail from the links offered by this site, you will be required to acknowledge these disclaimers.

Advertising

The material on this site may be considered paid publicity and may also be considered advertising in some jurisdictions. The hiring of a lawyer is an important decision that should not be based solely upon this or any other written information, and Verrill does not desire to represent clients based upon their review of any portions of this site that do not comply with legal or ethical requirements.

Designations

To the extent bar rules require us to designate a principal office and/or a single attorney responsible for this site, Verrill designates its office in Portland, Maine, USA as its principal office and designates Keith C. Jones as the attorney responsible for this site.

Privacy Policy

Attorneys, like all providers of personal financial services, are now required by law to inform their clients of their policies regarding privacy of client information. Attorneys have been and continue to be bound by professional standards of confidentiality that are even more stringent than those required by law. Therefore, we have always protected your right to privacy.

Types of Nonpublic Personal Information We Collect

We may collect nonpublic personal information about you that is provided to us by you or obtained by us with your authorization.

Parties to Whom We Disclose Information

For current and former clients, we do not disclose any nonpublic personal information obtained in the course of our practice except as required or permitted by law, or by order of Court. Permitted disclosures include, for instance, providing information to our assistants and employees, and in limited situations, to unrelated third parties who need to know that information to assist us in providing services to you. In all such situations, we stress the confidential nature of information being shared.

Protecting the Confidentiality and Security of Current and Former Clients' Information

We retain records relating to professional services that we provide so that we are better able to assist you with your professional needs and, in some cases, to comply with professional guidelines. In order to guard your nonpublic personal information, we maintain physical, electronic, and procedural safeguards that comply with our professional standards.

Please call William C. Knowles at (207) 774-4000 if you have any questions. Your privacy, our professional ethics, and the ability to provide you with quality legal services are very important to us.

Firm Highlights

Blog

IRS Allows Tax-Advantaged Leave Donation to COVID-19 Relief Organizations

Under new guidance, the IRS will give favorable tax treatment to employees who donate leave to COVID-19 relief organizations. In IRS Notice 2020-46 , the agency announced that employees who donate paid leave for...

Blog

Proposed Regulations Clarify Application of Excise Tax under Code Section 4960

Proposed Regulations published by the Treasury Department last month provide helpful clarifications regarding the application of the excise tax under Section 4960 of the Internal Revenue Code of 1986, as amended (the “Code”). The...

Matter

2017 Emera Distribution Rate Case

Verrill represented Emera in its 2017 distribution rate case before the Maine PUC, which included: defeating Staff's proposed reduction to allowed return on equity for "management inefficiency;" approval of new expenditures, such as an...

Publication/Podcast

PPP: How is Maine Faring?

Originally enacted on March 27, the Paycheck Protection Program (PPP) offers loan support and (potentially) loan forgiveness to qualifying small businesses – generally defined as those with not more than 500 employees. According to...

News

Paycheck Protection Program Focuses on Short-Term and Misses Long-Term Damages

On June 8, the Portland Press Herald published an article, "Revamped emergency loan program remains a short-term fix," discussing the Paycheck Protection Program's (PPP) extended deadlines and loosened restrictions, but lack of solutions to...

News

Verrill Welcomes Esteemed Corporate and Securities Attorney Edward Rosenthal

(June 10, 2020) – Verrill is pleased to welcome corporate and securities attorney Edward Rosenthal to the firm as a member of the Business Law Group. Rosenthal brings with him more than 40 years...

Event

2020 OHRP Exploratory Workshop

Health care attorney Emily Fogler will be presenting at the 2020 OHRP Exploratory Workshop in the third session, discussing sharing responsibilities and protecting participants - redefining roles in the single IRB era. Stay tuned...

Blog

Support for the Black Lives Matter Movement: Third-Party Intervention Training

This is the fifth post in a 12-part series on how companies can show support for the Black Lives Matter movement by changing company policies and practices. This post focuses on the importance of...

Publication/Podcast

FDA Issues Guidance on IRB Review of Non-Emergency Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products to Treat COVID-19

Prompted by a substantial increase in requests for individual patient access to investigational drugs and biologics to treat COVID-19, the U.S. Food & Drug Administration (“FDA”) issued guidance on June 2, 2020 that outlines...

Matter

Management Audit

Verrill represented Emera in its 2016 distribution rate case before the Maine PUC. The case involved issues relating to significant new capital investments, including Emera's new customer information system and a controversial substation investment...